Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Opioids Agonist Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Opioids Agonist Drugsmarket, defines the market attractiveness level of Opioids Agonist Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Opioids Agonist Drugs industry, describes the types of Opioids Agonist Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Opioids Agonist Drugs market and the development prospects and opportunities of Opioids Agonist Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Opioids Agonist Drugs market in Chapter 13.
By Player:
Allergan, Plc
Pfizer Inc
Egalet Corporation
Janssen Pharmaceuticals, Inc
Sun Pharmaceuticals
Endo Pharmaceuticals Inc
Purdue Pharma
Sanofi
Boehringer Ingelheim
Titan pharmaceuticals
Mallinckrodt Pharmaceuticals
By Type:
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
By End-User:
Pain Management
Cough Treatment
Diarrhea Treatment
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Opioids Agonist Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Opioids Agonist Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Opioids Agonist Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Opioids Agonist Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Opioids Agonist Drugs Market Analysis and Outlook to 2022
-
7.1 Global Opioids Agonist Drugs Consumption (2017-2022)
-
7.2 United States Opioids Agonist Drugs Consumption (2017-2022)
-
7.3 Europe Opioids Agonist Drugs Consumption (2017-2022)
-
7.4 China Opioids Agonist Drugs Consumption (2017-2022)
-
7.5 Japan Opioids Agonist Drugs Consumption (2017-2022)
-
7.6 India Opioids Agonist Drugs Consumption (2017-2022)
-
7.7 South Korea Opioids Agonist Drugs Consumption (2017-2022)
8 Region and Country-wise Opioids Agonist Drugs Market Analysis and Outlook to 2028
-
8.1 Global Opioids Agonist Drugs Consumption Forecast (2022-2028)
-
8.2 United States Opioids Agonist Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Opioids Agonist Drugs Consumption Forecast (2022-2028)
-
8.4 China Opioids Agonist Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Opioids Agonist Drugs Consumption Forecast (2022-2028)
-
8.6 India Opioids Agonist Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Opioids Agonist Drugs Consumption Forecast (2022-2028)
9 Global Opioids Agonist Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Opioids Agonist Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Codeine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Fentanyl Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Meperidine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Methadone Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Morphine Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Hydrocodone Consumption and Growth Rate (2017-2022)
-
9.2 Global Opioids Agonist Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pain Management Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cough Treatment Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diarrhea Treatment Consumption and Growth Rate (2017-2022)
10 Global Opioids Agonist Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Opioids Agonist Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Codeine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Fentanyl Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Meperidine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Methadone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Morphine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Hydrocodone Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Opioids Agonist Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cough Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diarrhea Treatment Consumption Forecast and Growth Rate (2022-2028)
11 Global Opioids Agonist Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Opioids Agonist Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Opioids Agonist Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Opioids Agonist Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Opioids Agonist Drugs Market Competitive Analysis
-
14.1 Allergan, Plc
-
14.1.1 Allergan, Plc Company Details
-
14.1.2 Allergan, Plc Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Allergan, Plc Opioids Agonist Drugs Product and Service
-
14.2 Pfizer Inc
-
14.2.1 Pfizer Inc Company Details
-
14.2.2 Pfizer Inc Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Inc Opioids Agonist Drugs Product and Service
-
14.3 Egalet Corporation
-
14.3.1 Egalet Corporation Company Details
-
14.3.2 Egalet Corporation Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Egalet Corporation Opioids Agonist Drugs Product and Service
-
14.4 Janssen Pharmaceuticals, Inc
-
14.4.1 Janssen Pharmaceuticals, Inc Company Details
-
14.4.2 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product and Service
-
14.5 Sun Pharmaceuticals
-
14.5.1 Sun Pharmaceuticals Company Details
-
14.5.2 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sun Pharmaceuticals Opioids Agonist Drugs Product and Service
-
14.6 Endo Pharmaceuticals Inc
-
14.6.1 Endo Pharmaceuticals Inc Company Details
-
14.6.2 Endo Pharmaceuticals Inc Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Endo Pharmaceuticals Inc Opioids Agonist Drugs Product and Service
-
14.7 Purdue Pharma
-
14.7.1 Purdue Pharma Company Details
-
14.7.2 Purdue Pharma Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Purdue Pharma Opioids Agonist Drugs Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Opioids Agonist Drugs Product and Service
-
14.9 Boehringer Ingelheim
-
14.9.1 Boehringer Ingelheim Company Details
-
14.9.2 Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Boehringer Ingelheim Opioids Agonist Drugs Product and Service
-
14.10 Titan pharmaceuticals
-
14.10.1 Titan pharmaceuticals Company Details
-
14.10.2 Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Titan pharmaceuticals Opioids Agonist Drugs Product and Service
-
14.11 Mallinckrodt Pharmaceuticals
-
14.11.1 Mallinckrodt Pharmaceuticals Company Details
-
14.11.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Opioids Agonist Drugs
-
Figure Opioids Agonist Drugs Picture
-
Table Global Opioids Agonist Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Opioids Agonist Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Opioids Agonist Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Opioids Agonist Drugs Consumption by Country (2017-2022)
-
Figure United States Opioids Agonist Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Opioids Agonist Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Opioids Agonist Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Opioids Agonist Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Opioids Agonist Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Opioids Agonist Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Opioids Agonist Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Opioids Agonist Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Opioids Agonist Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Opioids Agonist Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Opioids Agonist Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Opioids Agonist Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Opioids Agonist Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Codeine Consumption and Growth Rate (2017-2022)
-
Figure Global Fentanyl Consumption and Growth Rate (2017-2022)
-
Figure Global Meperidine Consumption and Growth Rate (2017-2022)
-
Figure Global Methadone Consumption and Growth Rate (2017-2022)
-
Figure Global Morphine Consumption and Growth Rate (2017-2022)
-
Figure Global Hydrocodone Consumption and Growth Rate (2017-2022)
-
Figure Global Pain Management Consumption and Growth Rate (2017-2022)
-
Figure Global Cough Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Diarrhea Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Codeine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fentanyl Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Meperidine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Methadone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Morphine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hydrocodone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cough Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diarrhea Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Opioids Agonist Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Opioids Agonist Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Allergan, Plc (Foundation Year, Company Profile and etc.)
-
Table Allergan, Plc Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan, Plc Opioids Agonist Drugs Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Opioids Agonist Drugs Product and Service
-
Table Egalet Corporation (Foundation Year, Company Profile and etc.)
-
Table Egalet Corporation Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Egalet Corporation Opioids Agonist Drugs Product and Service
-
Table Janssen Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product and Service
-
Table Sun Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceuticals Opioids Agonist Drugs Product and Service
-
Table Endo Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Endo Pharmaceuticals Inc Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo Pharmaceuticals Inc Opioids Agonist Drugs Product and Service
-
Table Purdue Pharma (Foundation Year, Company Profile and etc.)
-
Table Purdue Pharma Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue Pharma Opioids Agonist Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Opioids Agonist Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Opioids Agonist Drugs Product and Service
-
Table Titan pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Titan pharmaceuticals Opioids Agonist Drugs Product and Service
-
Table Mallinckrodt Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product and Service
-
